SLRN
Price:
$2.27
Market Cap:
$229.17M
Acelyrin, Inc. is a biopharmaceutical company focused on discovering, obtaining, and rapidly advancing the development and commercialization of innovative medical therapies. The firm's most advanced experimental drug is izokibep, a potent small protein therapeutic specifically designed to block IL-17A. This compound is currently undergoing Phase 3 clinical evaluations for its use in treating Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis. Additionally, izokibep is being assessed in Phase 2 clinical trials for Axial Spondyloarthritis. Beyond izokibep, Acelyrin is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets the insulin-like gro...[Read more]
Industry
Biotechnology
IPO Date
2023-05-04
Stock Exchange
NASDAQ
Ticker
SLRN
According to Acelyrin, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 176.86M. This represents a change of -30.39% compared to the average of 254.07M of the last 4 quarters.
The mean historical Enterprise Value of Acelyrin, Inc. over the last ten years is 226.63M. The current 176.86M Enterprise Value has changed 7.70% with respect to the historical average. Over the past ten years (40 quarters), SLRN's Enterprise Value was at its highest in in the March 2023 quarter at 1.46B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.
Average
226.63M
Median
254.96M
Minimum
89.42M
Maximum
307.16M
Discovering the peaks and valleys of Acelyrin, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 243.49%
Maximum Annual Enterprise Value = 307.16M
Minimum Annual Increase = -66.35%
Minimum Annual Enterprise Value = 89.42M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 244.18M | -20.50% |
| 2023 | 307.16M | 243.49% |
| 2022 | 89.42M | -66.35% |
The current Enterprise Value of Acelyrin, Inc. (SLRN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
213.59M
5-year avg
226.63M
10-year avg
226.63M
Acelyrin, Inc.’s Enterprise Value is greater than CARGO Therapeutics, Inc. Common Stock (109.02M), less than Inhibrx Biosciences, Inc. (1.20B), less than Cytocom, Inc. (224.44M), greater than Alaunos Therapeutics, Inc. (5.17M), greater than Catabasis Pharmaceuticals, Inc. (143.04M), greater than Third Harmonic Bio, Inc. (-25821436.00), less than Spectrum Pharmaceuticals, Inc. (199.44M), less than Merrimack Pharmaceuticals, Inc. (217.98M), greater than Celularity Inc. (51.87M), less than Inozyme Pharma, Inc. (279.36M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 109.02M | $216.19M | |
| 1.20B | $225.87M | |
| 224.44M | $226.39M | |
| 5.17M | $5.52M | |
| 143.04M | $234.86M | |
| -25821436.00 | $242.79M | |
| 199.44M | $210.38M | |
| 217.98M | $223.97M | |
| 51.87M | $17.15M | |
| 279.36M | $258.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acelyrin, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acelyrin, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Acelyrin, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Acelyrin, Inc. (SLRN)?
What is the 3-year average Enterprise Value for Acelyrin, Inc. (SLRN)?
What is the 5-year average Enterprise Value for Acelyrin, Inc. (SLRN)?
How does the current Enterprise Value for Acelyrin, Inc. (SLRN) compare to its historical average?